chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up at 7:00 AM and immediately noticed that I was unable to see and had severe blurred vision to the point I could not drive or read anything.  I went to facility on 01/19/17.  I saw Dr. who did a vision check on me and ordered blood work regarding the sudden loss of vision.  He consulted with neurologist who ordered a stat CT and MRI of the brain which were both normal.  The following day I was referred by my primary physician on 01/20/17 to ophthalmothy who dilated me eyes and diagnosed me with bilateral elevated intraocular pressure.  Eye drops were prescribed Dorzolamide-Timolol.  On January 22, 2017, I had no improvement on my vision and presented to the emergency room.  Dr. was called into the emergency room to perform a neurological evaluation which he said was normal and told me he did not know why I lost my vision and could not link in to anything neurologcial.  The emergency room doctor prescribed a seond eye drop to try to lower the eye pressure Brimonidine to be used with the other eye drops previously prescribed.  I have a follow-up appointment on January 25, 2017 at 2:15pm with ophthalmology.
After my first dose, I was achy; I was very tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Lot number: ER8729) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "After my first dose, I was achy"; FATIGUE (non-serious), outcome "unknown", described as "I was very tired". Additional information; The patient received the second dose Lot: EW0175, and experienced no side effects.  No follow-up attempts are possible. No further information is expected.
As stated by patient, (3) hours after vaccines I couldn't breathe so I went to emergency room and received BENADRYL. (12) hours after that I couldn't move my right arm and it was numb. I went back to hospital and they gave me steroids. Today, 1/20/2012 I have numbness in head, both arms, legs, and it is hard to walk.
Very itchy rash which started out in left axilla then spread to right axilla, then right upper anterior chest, then lower chest bilaterally, then to right forearm, then to left forearm.  Rash is ongoing for almost 7 months and continues to spread and be very red, itchy and painful.  Keeps me up at night and I many of my clothes are uncomfortable to wear.  I?ve never had a rash like this.  For 40 years my Dowling Degos disease has never been bothersome nor has it flared up like this.
vaccine given 6days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6days post expiry) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported   This case was linked to MOD-2021-395985 (Patient Link).
Negative Titer After Receiving Both Doses; Initial Report Received on 30-Nov-2021  A pharmacist reported that a female patient (age, race and ethnicity not provided) received both doses of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and had a negative titer.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On an unspecified date, the patient received the first dose of HEPLISAV-B (Lot #, expiration date and NDC # not reported) in an unknown route and site.  On an unspecified date in September 2021, one month after receiving the first dose of HEPLISAV-B, the patient received the second dose of HEPLISAV-B (Lot #, expiration date and NDC # not reported) in an unknown route and site.  On 25-Nov-2021, the patient's titers were drawn and had a negative titer.  No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
severe burning in my spinal cord and described it as bad, as she was squirming; pain; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), first dose via an unspecified route of administration on 05Mar2021 (lot number and expiration date were not reported) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had the covid vaccine on 05Mar2021 and had a "severe burning in my spinal cord" and described it as bad, as she was squirming. The patient was in pain. The outcome of the events was unknown.   No follow-up attempts are completed; information about lot/batch number cannot be obtained
PARALYSIS OF LOWER EXTREMITIES; INJURED; WEIGHT LOSS; MEMORY LOSS; HEARTBURN; CONSTIPATION; IMPAIRED/BLURRED VISION; SLEEP DISTURBANCE; HEART ISSUES; MENTAL STATUS CHANGES; ELEVATED BLOOD PRESSURE; MUSCLE TWITCHING; ELEVATED HEART RATE; CHEST PAIN; MUSCLE SPASMS; BRAIN FOG; BULGING VEINS; INTERNAL VIBRATIONS AND TREMORS; FACIAL AND SINUS PRESSURE; DIZZINESS; SEVERE WEAKNESS; FATIGUE; HEADACHES; PAINFUL PARESTHESIA THROUGHOUT THE BODY, FACE, TONGUE, SCALP; DIARRHEA; TINNITUS; NAUSEA; This spontaneous report received from a physician concerned multiple patients of unspecified race and ethnicity. No past medical history or concurrent conditions were reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  The reporter reported that, on an unspecified date, "the patients experienced very similar adverse reactions to vaccines. The reactions included nausea, weight loss, heartburn, diarrhea or constipation, sleep disturbances, chest pains, headaches, facial and sinus pressure, dizziness, severe weakness and fatigue, painful paresthesia throughout the body, severe painful paresthesia focused on the face, tongue and scalp, internal vibrations and tremors, muscle twitching and muscle spasms, brain fog and mental status changes, memory loss, tinnitus, impaired or blurred vision, elevated blood pressure of 186 over 127 and heart rate, bulging veins, heart issues and weakness. Several in their group experienced paralysis of the lower extremities and to this day remain paralyzed.  These patients were previously healthy individuals and reactions occurred within minutes to a few short days after receiving the vaccines".  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from paralysis of lower extremities, and the outcome of injured, nausea, weight loss, heartburn, diarrhea, constipation, sleep disturbance, chest pain, headaches, facial and sinus pressure, dizziness, severe weakness, fatigue, painful paresthesia throughout the body, face, tongue, scalp, internal vibrations and tremors, muscle twitching, muscle spasms, brain fog, mental status changes, memory loss, tinnitus, impaired/blurred vision, elevated blood pressure, elevated heart rate, bulging veins and heart issues was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20211021799 -COVID-19 VACCINE AD26.COV2.S-  paralysis of lower extremities. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
8-12-2021 around 12 noon fever spiked to over 102, started alternating aleve and tylenol every four hours for six days,   then arms aching from elbows to hands and legs from knees down to toes, joints on all constant stiffness. Spikes of headaches on and off the whole time. Last signs weened off 8-26-2021
Patient started to have lip tingling and itching throat 5 minutes after vaccination.  Patient was given benadryl and famotidine.  Patient's husband took her to the emergency room to be monitored.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 71-year-old female patient who received SHINGRIX (batch number 37KL2, expiry date 12th February 2021) for prophylaxis. On 25th July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, 14 days after receiving SHINGRIX, the patient experienced pain in arm and pain in joint involving forearm. The patient was treated with prednisone. On an unknown date, the outcome of the pain in arm and pain in joint involving forearm were unknown. It was unknown if the reporter considered the pain in arm and pain in joint involving forearm to be related to SHINGRIX. Additional details were provided as follows: This case was reported via online chat. The patient had a possible adverse events. Two weeks after vaccination, the patient experienced a lot of pain in right arm (from wrist to elbow) and described it as the pain at skin surface. The pain was severe enough that her primary care provider prescribed prednisone to treat it. The patient had pain for over a week. The patient was wondered if this could had been from SHINGRIX and should she receive the 2nd dose of SHINGRIX.
suspected vaccination failure; got them; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in an unspecified number of patient's who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The age at vaccination was not applicable. The reporter stated that, he/she had talked to many who got shingles after receiving Shingles shot. The reporter said, it might not work on everybody. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided. This case had been linked with case US2021AMR166251, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR166251:same reporter
Child woke 5am next day both thighs were swollen and red, temp 100. Unable to bend legs and was in discomfort. I the mother gave child TYLENOL and warm rag. Called doctor when opened. She went back to sleep at 9am gave child morning and a bath with episom salt. Doctor office called back temp had when down. Nurse said to continue pain meds us needed. I alternated TYLENOL and MOTRIN. Swelling same but not worse.
Vaccination site started to become red, swollen, and irritated Told patient to take a benadryl and ice the area. If no improvement, or worsening symptoms by end of day today, seek medical care.
After the second dose of the vaccine, I began to experience a ?pins and needles? sensation on occasion in my upper body. It starts one location and the sensation spreads a bit and then clears.  I got Covid in January, and the sensation still persisted on occasion when I would sneeze.
received only the liquid portion; received only the liquid portion; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a adolescent female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMCA602A, expiry date 31st August 2022) for prophylaxis.   On 9th November 2021, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional details were reported as follows: The age at vaccination was not reported. The registered nurse reported that patient received only the liquid portion of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up. This case has been linked with US2021AMR238864, US2021238417, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR238864:same reporter US-GLAXOSMITHKLINE-US2021238417:same reporter
Patient is 16 years old, male.  Inadvertently received a 2nd BOOSTER Pfizer COVID vaccine GRAY CAP 0.3 mL on his left deltoid today--07/07/2022. Lot # FM7553, exp date: 07/28/2022.  Received Pfizer 1st dose: 05/16/2021 Received Pfizer 2nd dose: 06/07/2021 Received Pfizer Booster: 01/29/2022
Pt reports rash, hive like spots appeared on chest day after receiving #2 Hep B. Spots itch. Friday morning (2 days after, increased spots, stomachache , malaise, insomnia.
I was still inside my car inside the parking lot when the left side of my face started tingling then went numb.  I recall having the exact sensation years before when I got Bells Palsy, so I looked in my purse for my liquid B-12 supplement that I take on a daily basis and had one droplet and waited in the car(I was by myself).  20 minutes later the affected side started to move again.  Immediately after the numbness was over, my left warm got red(I cannot tell whether it was rash or just redness)
About 5 min  after inj, pt c/o dizziness. Pt is fully awake, alert, coherent. Skin warm/dry. Color n/l. Resp easy/reg. 1215 bp sitting 88/48 -HR 55/m -RR 18/m. Then, c/o nausea. 1220p bp sitting on floor now 163/76 HR 69/m. When asked last meal, he only had cup of tea. Reg oj given. Tol sips. 1225 bp sitting 121/102 HR 55/m RR 18 reg. Per pt, feeling better. 1235 instr to eat lunch. In the future if going for vaccination, to inform Provider about his anxiety w  injection. Left store ambulatory , stable w wife.
Initial report received from the health care professional (nurse) on 21 Jul 2010: On 21 Jul 2010, this child was vaccinated with an intramuscular injection of only the MenCWY conjugate of MENVEO (batch number: 091101), (dose: unknown) without being reconstituted with the MenA component. No adverse effects were noted following this administration.
This spontaneous report was received from a Licensed Practical Nurse, referring to an unspecified number of patients. Age, genders, medical history or concurrent conditions were not reported. On an unknown date, doses of VAQTA (L018499, exp date: 25-FEB-2017: L015460, exp date: 20-JUL-2017; L036300 exp date: 04-NOV-2016) (dose and route were not reported) which were exposed to temperatures outside of the recommended range were administered to the unspecified number of patients. It was unknown if the patient sought medical attention. No adverse refers that there was no product quality complaints involved. This is one of several reports from the same source. Lot number L036300 has been verified to be a valid lot number for Hepatitis A vaccine, Inactivated. Additional information has been requested.
Mother states 3 hours after flu vaccine, fever, shaking - calmed by Tytra blanket, dry heaves, tired/weak, still eating, walking normally.
On June 16, 2022 I had a sore throat and a cough that got worse by June 17, 2022 and I also wanted to sleep more and had body aches. The sore throat was worse than any strep throat I ever had. I called my Primary Care Physician and was prescribed PAXLOVID and started taking on June 18, 2022. After taking it for five days my wife and I were better then we started feeling ill again on June 28, 2022. We retested with our home COVID-19 test and were positive again so we quarantined until July 5, 2022 until were negative.
pt recvd vax 13AUG93 & 16AUG93 w/red tender, mildly swollen lt deltoid; given Celestone; c/o difficulty swallowing, throat swelling, rt jaw spasms w/h/a, fever, & fatigue;
In the first 5 days after the injection, I had regular bouts of shortness of breath.  Usually, after exertion (stairs) or in the evenings. This past week (12/7/2021), I called my PCP - and notified the office that my shortness of breath was still continuing.  On  12/9/2021, I was advised by the office to be seen by a medical professional ASAP and they strongly recommended I visit an urgent care.  That evening, around 7:30PM, I went to the Urgent Care and was treated by a doctor who recommended that I get straight to an Emergency Room to properly rule out blood clots in my lungs. I drove from the Urgent Care to the Hospital Emergency Room. Thankfully, Doctor called ahead.  I arrived at the ER and was immediately given an EKG, blood draws, and a chest X-Ray.  I then waited a few hours for my Chest CT.  Dr. confirmed that my EKG, blood tests, chest X-Ray, and Chest CT were all clear.  In discussing my medical options, he suggested an oral steroid, which would aggravate my diabetes.  I ended up on Flovent, which I am currently continuing until my follow up with my pcp.
Pneumonia; bit sick; Dry cough; Pain at the site of the injection; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Pneumonia) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced CHEST PAIN (Chest pain) and VACCINATION SITE PAIN (Pain at the site of the injection). On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant), ILLNESS (bit sick) and COUGH (Dry cough). At the time of the report, PNEUMONIA (Pneumonia), CHEST PAIN (Chest pain), ILLNESS (bit sick), COUGH (Dry cough) and VACCINATION SITE PAIN (Pain at the site of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was diagnosed with Asthma around 17-Jul-2021 and was prescribed an inhaler.  Patient reported that his condition has not improved and stated that he has pneumonia and a dry cough that hurts. He said he was a bit sick when he got the vaccine but was told that it was okay to get the 1st dose (Patient has not received the 2nd).  Concomitant medication: INHALER.  Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 18-Aug-2021: Follow-up information received included events pneumonia, dry cough and sickness were added, case seriousness was upgraded from non-serious to serious due to the newly added serious event pneumonia.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
chills; pains in her body; spasms; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took Benadryl for hypersensitivity. The patient experienced chills, pains in her body and spasms on an unspecified date (about 3-4 day after vaccination) with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient began experiencing light headed and feeling warm. Patient has history of low blood glucose post procedures. Pharmacy provided patient with glucose tabs and water. Patient also had a snicker bar post vaccination to prevent low blood sugar. Three to five minutes later patient had briefly passed out but was breathing normally. Also, witnessed some muscle rigidity in legs and arms reminiscent of seizure activity but quickly recovered. Patient continued to breath normally. EMS were called and patient was responsive at the arrival of EMS. No signs of anaphylaxis at any point were witnessed by the pharmacist.
Lighted headed, dizzy, cold clammy skin, history of these type symptoms with injections.
Reporter states 19 year old female received Menactra on 12/28/06. On Jan. 7, 2007, patient reported tingling sensation from feet to thighs. Returned to school. Will be seen by physician.
had her 10 year old well check up on  12/13/2021 with Dr where we discussed her current health and that she was in a normal 10 year old.  No signs that indicated she would begin her period until a few years from now (no breast buds, hair, etc.).  2 days later began her menses that lasted over 7 days.  We reached out to her pediatrician who was shocked that this would happen and so we underwent a series of tests including a bone scan and blood tests to check hormones etc.  All of these records are available and Dr. is available to discuss.
Pt recvd 2nd dose of Hep B vax & devel a fever of 101 & arthralgia; pt was out of work x 3 days;
At 1800, noted dime size erythemia at SQ injection site of the Varicella vaccine on Left upper arm.  On 04/09/09 at 1215, area measured 4 x 3 cm and was red, hard, warm, and itching.  The largest size noted extended to 3 cm proximal to left elbow and 3 cm proximal to the left upper arm with warmth, erythemia, and itching.  Patient took Xyzal 5 mg po x 1 day and applied topical hydrocortisone cream PRN for 4 days.  By 09/12/2009, most symptoms had resolved.  On 19/13/2009, all symptoms resolved.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 16-MAR-2016, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) lot # L042818, expiration date: 26-APR-2017, 0.5 ml, subcutaneously. The vaccine was exposed to temperature of 46.8 Fahrenheit degrees for 16.5 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.